LGD · Class II · 21 CFR 866.3780

FDA Product Code LGD: Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii

Toxoplasma gondii infection poses serious risks to immunocompromised patients and fetuses. FDA product code LGD covers enzyme-linked immunosorbent assay systems for Toxoplasma gondii antibody detection.

These immunoassays detect IgG and IgM antibodies against Toxoplasma gondii in serum, enabling the diagnosis of acute and past infection. IgM detection is critical in pregnant women to identify primary infection that poses a risk of congenital toxoplasmosis.

LGD devices are Class II medical devices, regulated under 21 CFR 866.3780 and reviewed by the FDA Microbiology panel.

Leading manufacturers include Abbott Laboratories, Beckman Coulter, Inc. and Diagnostic Products Corp..

106
Total
106
Cleared
155d
Avg days
1982
Since
Growing category - 3 submissions in the last 2 years vs 0 in the prior period
Review times increasing: avg 202d recently vs 154d historically

FDA 510(k) Cleared Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii Devices (Product Code LGD)

106 devices
1–24 of 106
Cleared Mar 28, 2025
Access Toxo IgG
K242022
Beckman Coulter, Inc.
Microbiology · 260d
Cleared Oct 11, 2024
Access Toxo IgM II
K242095
Beckman Coulter, Inc.
Microbiology · 86d
Cleared Aug 30, 2024
Alinity i Toxo IgM
K233932
Abbott Laboratories
Microbiology · 260d
Cleared May 19, 2022
ARCHITECT Toxo IgG
K210596
Abbott Laboratories
Microbiology · 444d
Cleared Jun 23, 2017
Elecsys Toxo IgM, Elecsys Toxo IgM PreciControl
K162678
Roche Diagnostics
Microbiology · 270d
Cleared May 18, 2011
VIDAS TOXO IGG AVIDITY
K101946
bioMerieux, Inc.
Microbiology · 310d
Cleared Jun 09, 2008
ROCHE ELECSYS TOXO IGG TEST SYSTEM, ROCHE ELECSYS PRECICONTROL TOXO IGG
K073501
Roche Diagnostics Corp.
Microbiology · 179d
Cleared May 23, 2008
ACCESS TOXO IGG, ACCESS TOXO IGG CALIBRATORS AND ACCESS TOXO IGG QC
K080869
Beckman Coulter, Inc.
Microbiology · 53d
Cleared Aug 08, 2003
ACCESS IMMUNOASSAY SYSTEM TOXO IGG ASSAY
K032162
Beckman Coulter, Inc.
Microbiology · 24d
Cleared Jun 02, 2003
ACCESS IMMUNOASSAY SYSTEM TOXO IGM II ASSAY
K031506
Beckman Coulter, Inc.
Microbiology · 19d
Cleared Sep 30, 2002
BIO-RAD PLATELIA TOXO IGM TMB
K013837
Bio-Rad
Microbiology · 315d
Cleared Sep 30, 2002
BIO-RAD PLATELIA TOXO IGG TMB
K013839
Bio-Rad
Microbiology · 315d
Cleared Jan 10, 2002
IMMULITE TOXOPLASMA IGM, MODEL LKTM1 AND LKTM2, IMMULITE 2000 TOXOPLASMA IGM, MODEL L2KTM2 AND L2KTM6
K012075
Diagnostic Products Corp.
Microbiology · 192d
Cleared Jun 13, 2001
ACCESS TOXO IGM II REAGENTS FOR USE ON THE ACCESS IMMUNOASSAY SYSTEMS, MODEL 34470,34475,34479
K003259
Beckman Coulter, Inc.
Microbiology · 238d
Cleared Aug 31, 2000
ACCESS TOXO IGM II REAGENTS FOR USE ON THE ACCESS IMMUNOASSAY SYSTEMS, MODELS 34470, 34475, AND 34479
K002453
Beckman Coulter, Inc.
Microbiology · 21d
Cleared May 22, 2000
VIDAS TOXO IGG II (TXG) ASSAY MODEL 30 210
K993319
bioMerieux, Inc.
Microbiology · 231d
Cleared Sep 17, 1998
ACCESS TOXOPLASMA IGM REAGENTS ON THE ACCESS IMMUNOASSAY ANALYZER, MODELS 34460, 34465, 34469
K973448
Beckman Instruments, Inc.
Microbiology · 371d
Cleared Apr 24, 1997
IMMULITE TOXOPLASMA QUANTITATIVE IGG
K962936
Diagnostic Products Corp.
Microbiology · 269d
Cleared Aug 23, 1996
AXSYM TOXO IGM
K954576
Abbott Laboratories
Microbiology · 326d
Cleared Aug 16, 1996
AXSYM TOXO IGG ANTIBODY ASSAY
K954575
Abbott Laboratories
Microbiology · 319d
Cleared Feb 23, 1996
IMMULITE TOXOPLASMA GONDII IGG
K950671
Diagnostic Products Corp.
Microbiology · 375d
Cleared Aug 01, 1995
IMX TOXO IGG
K951636
Abbott Laboratories
Microbiology · 116d
Cleared Apr 27, 1995
IMX(R) TOXO IGM
K945634
Abbott Laboratories
Microbiology · 162d
Cleared Nov 29, 1991
ABBOTT IMX TOXO IGM POSITIVE CONTROL
K913106
Abbott Laboratories
Microbiology · 140d

About Product Code LGD - Regulatory Context

510(k) Submission Activity

106 total 510(k) submissions under product code LGD since 1982, with 106 receiving FDA clearance (average review time: 155 days).

Submission volume has increased in recent years - 3 submissions in the last 24 months compared to 0 in the prior period - suggesting growing market activity in this device classification.

FDA 510(k) Review Time - LGD Product Code

Recent submissions under LGD have taken an average of 202 days to reach a decision - up from 154 days historically. Manufacturers should account for longer review timelines in current project planning.

LGD devices are reviewed by the Microbiology panel. Browse all Microbiology devices →